All In Biotech

Free tool

FAERS Monitor: Januvia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021995 or its brand name (Januvia, Sitagliptin Phosphate). Reports on generic versions are filed under their own applications.

Reports

72,446

Serious

46,797

65% of reports

Hospitalization

25,261

Death reported

6,838

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased4,520
  • nausea3,964
  • diarrhoea3,630
  • drug ineffective3,575
  • fatigue3,003
  • headache2,582
  • dizziness2,508
  • vomiting2,462
  • dyspnoea2,402
  • acute kidney injury2,283
  • pancreatitis2,231
  • death2,218
  • asthenia2,146
  • malaise1,964
  • weight decreased1,948

Reports by year received

View as table
YearReports
200627
20073,569
20082,411
20092,444
20101,757
20111,967
20122,836
20133,661
20144,463
20156,599
20165,273
20174,741
20185,086
20195,057
20204,557
20213,805
20223,621
20232,891
20242,851
20252,804
20262,026

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,981,713 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pancreatitisSignal2,23112.812.223,191
blood glucose increasedSignal4,5207.16.923,374
acute kidney injurySignal2,2834.44.25,909
weight decreasedSignal1,9482.01.91,028
asthenia2,1461.71.6570
diarrhoea3,6301.61.6921
vomiting2,4621.51.5449
dizziness2,5081.51.4373
nausea3,9641.51.4586
malaise1,9641.31.2139
dyspnoea2,4021.21.2108
headache2,5821.21.285
fatigue3,0031.11.140
drug ineffective3,5750.80.8219
death2,2180.70.7198

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.